Pathological movement patterns

Pathological movement patterns refer to a broad spectrum of abnormal motor behaviors resulting from neurological dysfunction, typically involving the basal ganglia, cerebellum, or their associated pathways [1]. These patterns are clinically categorized into hyperkinetic movements, such as tremors, chorea, tics, and dystonia, and hypokinetic movements, such as bradykinesia and rigidity [3]. They are hallmark manifestations of various neurodegenerative and neurological conditions, including Parkinson's disease and Huntington's disease [2]. Because these patterns represent clinical phenotypes rather than specific molecular entities, they are not classified as therapeutic targets in the traditional pharmacological sense. Instead, they serve as the primary clinical endpoints for evaluating the efficacy of drugs that target specific receptors or enzymes involved in motor regulation. Pharmacological management focuses on restoring neurochemical balance, often by modulating dopaminergic, cholinergic, or GABAergic signaling to alleviate symptoms and improve motor function [1][3]. [1] StatPearls, 'Movement Disorders' (2023); [2] NINDS, 'Motor Control and Movement Disorders' (2023); [3] Mayo Clinic, 'Movement disorders' (2023).

Other names

Movement disordersAbnormal motor patternsDyskinesiaMotor dysfunctionHyperkinesiaHypokinesia

Therapeutic interventions do not target the movement patterns themselves but rather the underlying neurochemical imbalances; strategies include dopamine receptor agonism, VMAT2 inhibition to deplete presynaptic dopamine, and GABAergic modulation to reduce neuronal excitability [1][2].